New antibodies could lead to first monoclonal treatment for measles
Vanderbilt Health researchers and colleagues have isolated human monoclonal antibodies from previously infected individuals that potently neutralized the measles virus in the laboratory and strongly inhibited viral replication in two animal models.
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.